187 completed, 50 recruiting, 29 terminated, 21 unknown. 336 Phase 1, 123 Phase 2.
Follow Peripheral Nervous System Diseases: new trials by email Literature Review of Peripheral Nervous System Diseases trials Research Report on Peripheral Nervous System Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A | Phase 1 / Phase 2 | Withdrawn | Nationwide Children's Hospital | 2027-04-01 | 2026-07-29 | |
| Simultaneous Engagement of Networks for Alleviating Pain (SENAP) PFM-guided cortical stimulation - Neuropathic Pain, Postherpetic Neuralgia | Phase 1 | Not yet recruiting | University of Minnesota | 20 | 2027-01-01 | 2026-11-03 |
| Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy GEB-101 Injection - Hereditary Corneal Dystrophy, Corneal Abnormality | Phase 1 / Phase 2 | Not yet recruiting | GenEditBio Limited | 30 | 2026-10-01 | 2026-09-10 |
| Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain Green Tea Leaf Extract Decaffeinated, Placebo Control - Neuropathic Pain, Cancer Treatment | Phase 1 | Not yet recruiting | University of Alabama at Birmingham | 20 | 2026-09-30 | 2026-08-21 |
| OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis glibenclamide, Placebo - Multiple Sclerosis, Neuropathic Pain | Phase 1 | Not yet recruiting | University of Maryland, Baltimore | 10 | 2026-09-01 | 2025-10-28 |
| Psilocybin to Treat Depression in Spinal Cord Injury Psilocybin (Usona Institute) - Spinal Cord Injury, Depression - Major Depressive Disorder | Phase 1 / Phase 2 | Recruiting | James J. Peters Veterans Affairs Medical Center | 30 | 2026-08-06 | 2026-08-10 |
| Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST | Phase 1 / Phase 2 | Recruiting | Ankit Mangla, MD | 17 | 2026-08-01 | 2026-08-11 |
| A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors ARV-6723, Pembrolizumab, SOC - Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Arvinas Inc. | 499 | 2026-07-29 | 2026-10-13 |
| An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Obinutuzumab β - Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Obinutuzumab β | Phase 1 / Phase 2 | Not yet recruiting | Zhongming Qiu | 24 | 2026-07-15 | 2026-07-10 |
| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants Y-4 tablet, Pregabalin capsule, Riluzole tablet - Healthy Male and Female Subjects | Phase 1 | Not yet recruiting | Neurodawn Pharmaceutical Co., Ltd. | 11 | 2026-06-30 | 2026-06-01 |
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection [89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 40 | 2026-06-15 | 2026-10-01 |
| Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas Cabozantinib Oral Tablet, Selumetinib Oral Capsule - Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 | Recruiting | Girish Dhall, MD | 30 | 2026-06-09 | 2026-10-02 |
| Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer GB-4362, enfortumab vedotin (EV), Pembrolizumab - Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma | Phase 1 | Recruiting | Generate Biomedicines | 37 | 2026-06-08 | 2026-10-13 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1) | Phase 1 / Phase 2 | Recruiting | AeRang Kim | 45 | 2026-06-01 | 2026-07-27 |
| Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury EC5026 oral tablet, Placebo oral tablet - Spinal Cord Injuries, Neuropathic Pain | Phase 1 | Recruiting | EicOsis Human Health Inc. | 36 | 2026-05-01 | 2026-07-10 |
| Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer Serabelisib, Sapanisertib, Fulvestrant - HR+ HER2- Breast Cancer | Phase 1 / Phase 2 | Recruiting | Faeth Therapeutics | 32 | 2026-04-22 | 2026-07-02 |
| Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment KITE-363, Fludarabine, Cyclophosphamide - Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis | Phase 1 | Recruiting | Kite, A Gilead Company | 57 | 2026-04-10 | 2026-10-19 |
| HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia HPB-092 tablet - Relapsed and Refractory Acute Myeloid Leukemia (RR-AML) | Phase 1 | Recruiting | Hangzhou Polymed Biopharmaceuticals, Inc. | 60 | 2026-04-10 | 2026-07-23 |
| Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study Cannabidiol (CBD) oral solution, Full-Spectrum CBD hemp extract oral solution, Placebo in MCT oil oral solution - Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies | Phase 1 / Phase 2 | Recruiting | Florida A&M University | 20 | 2026-04-02 | 2026-04-29 |
| Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. Universal CD19 CAR-γδT Cell Injection, Cyclophosphamide, Fludarabine - Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorder (NMOSD) | Phase 1 | Recruiting | Tongji Hospital | 6 | 2026-04-01 | 2026-05-12 |
Showing 20 of 336. Sign in to see all of them.
Neuralgia (70) · Hereditary Sensory and Autonomic Neuropathies (55) · Neurofibrosarcoma (35) · Neurofibromatosis 1 (30) · Diabetic Neuropathies (26) · Sarcoma (24) · Pain (19) · Sarcoma, Synovial (16) · Breast Neoplasms (15) · Chronic Pain (14) · Neuralgia, Postherpetic (14) · Rhabdomyosarcoma (13) · Carpal Tunnel Syndrome (12) · Leiomyosarcoma (12)
Nervous System Diseases (334) · Neuromuscular Diseases (334) · Pathological Conditions, Signs and Symptoms (134) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (123) · Genetic Diseases, Inborn (120) · Neurodegenerative Diseases (116) · Heredodegenerative Disorders, Nervous System (110) · Neoplasms (109) · Signs and Symptoms (108) · Neurologic Manifestations (107) · Neoplasms by Histologic Type (96) · Polyneuropathies (85) · Pain (81) · Neoplasms, Nerve Tissue (77)
AZD 6244 (9) · Lidocaine (7) · pembrolizumab (7) · Everolimus (5) · Fulvestrant (5) · Cetuximab (4) · Deoxycholic Acid (4) · Pregabalin (4) · Sodium Chloride (4) · fludarabine (4) · vixotrigine (4) · 6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-one (3) · Cyclophosphamide (3) · Doxorubicin (3) · Immunoglobulins, Intravenous (3)
National Cancer Institute (NCI) (14) · AstraZeneca (9) · Biogen (8) · Massachusetts General Hospital (6) · Washington University School of Medicine (5) · Center for Medicinal Cannabis Research (4) · Novartis Pharmaceuticals (4) · Novartis Vaccines (4) · Stanford University (4) · Cascadian Therapeutics Inc. (3) · Children's Hospital Medical Center, Cincinnati (3) · GL Pharm Tech Corporation (3) · Johns Hopkins University (3) · University Children's Hospital, Zurich (3) · University of Alberta (3)
United States (186) · Canada (25) · United Kingdom (25) · China (22) · Spain (19) · Australia (17) · South Korea (16) · France (15) · Switzerland (14) · Netherlands (10) · Germany (9) · Japan (9) · Egypt (8) · Belgium (7) · Denmark (7)
Brigitte C Widemann, M.D. (4) · Richard R Anderson, MD (3) · Simon Haroutounian, PhD (3) · AeRang Kim, MD, PhD (2) · Albert Lo, MD PhD (2) · Jason R Fangusaro (2) · Min-Gul Kim, Ph.D. (2)
PMID 35295458, PMID 38507752, PMID 11145807, PMID 11705489, PMID 12384756, PMID 12473512, PMID 12528778, PMID 12897484, PMID 12957454, PMID 15010069, PMID 15115710, PMID 15454701, PMID 15592836, PMID 16192528, PMID 16371894, PMID 16466122, PMID 17296917, PMID 18362604, PMID 19027342, PMID 19088049, PMID 19356391, PMID 19387178, PMID 19717722, PMID 19800329, PMID 19801812, PMID 20798179, PMID 21047224, PMID 21185118, PMID 21764354, PMID 21764821, PMID 22048718, PMID 22262746, PMID 22934754, PMID 23131255, PMID 23325902, PMID 23382028, PMID 23798472, PMID 24088271, PMID 24327173, PMID 25218827, PMID 25858498, PMID 25885543, PMID 25962165, PMID 26032776, PMID 26381530, PMID 26928074, PMID 28029918, PMID 28158151, PMID 29023494, PMID 29066505
2017 (4), 2023 (3), 2014 (2), 2015 (2), 2018 (2), UM1CA081457 (2), 2005 (1), 2016 (1), 2019 (1), 2025 (1), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA008748 (1), P30CA014599 (1)